Cargando…
Prospects for Development of Induced Pluripotent Stem Cell-Derived CAR-Targeted Immunotherapies
Technologies required to generate induced pluripotent stem cells (iPSC) were first described 15 years ago, providing a strong impetus to the field of regenerative medicine. In parallel, immunotherapy has finally emerged as a clinically meaningful modality of cancer therapy. In particular, impressive...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666432/ https://www.ncbi.nlm.nih.gov/pubmed/34897554 http://dx.doi.org/10.1007/s00005-021-00640-7 |